These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Droperidol vs. haloperidol in the initial management of acutely agitated patients.
    Author: Resnick M, Burton BT.
    Journal: J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480.
    Abstract:
    In a double-blind clinical study, 27 acutely agitated patients were treated with an intramuscular injection of 5 mg of droperidol or 5 mg of haloperidol from identical appearing vials. At 30 minutes following treatment, 81% of the patients treated with haloperidol but only 36% treated with droperidol required a second injection (p less than .05). Thus, droperidol, a safe butyrophenone neuroleptic, appears to be a drug of choice for rapid and reliable control of acute agitation.
    [Abstract] [Full Text] [Related] [New Search]